Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Cold” tumors are resistant to common immunotherapies. Stanford Medicine researchers have uncovered a master regulator that ...

Interestingly, the team noted, “EPO, a glycoprotein hormone known for stimulating red blood cell production, has recently been implicated in other biological processes involving resolution of ...

EPO, also referred to as erythropoietin, is a hormone naturally produced by the kidneys that promotes the production of red blood cells. More red blood cells enable your muscles to get more oxygen ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not ...

However, this glycoprotein hormone has prothrombotic properties ... and colleagues have found that subcutaneous administration of erythropoietin is associated with an increased risk of access ...

It was shown, using sensitive radioimmunoassays, that neither physical exercise nor training has any significant effect on serum EPO level. However, the measurements taken during the postexercise ...